Last update 30 Aug 2025

MAXCAPs

Overview

Basic Info

Drug Type
Fusion protein
Synonyms-
Target
ADCYAP1R1
Action
agonists
Mechanism
ADCYAP1R1 agonists(Pituitary adenylate cyclase-activating polypeptide type I receptor agonists)
Therapeutic Areas
Digestive System Disorders
Active Indication-
Inactive Indication
Metabolic dysfunction-associated steatotic liver diseaseNonalcoholic Steatohepatitis
Originator Organization
Bausch Health Cos., Inc.Bausch Health Cos., Inc.University of California, Los AngelesUniversity of California, Los AngelesSalix Pharmaceuticals, Inc.Salix Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Salix Pharmaceuticals, Inc.Salix Pharmaceuticals, Inc.Bausch Health Cos., Inc.Bausch Health Cos., Inc.University of California, Los AngelesUniversity of California, Los Angeles
License Organization
University of CaliforniaUniversity of CaliforniaSalix Pharmaceuticals, Inc.Salix Pharmaceuticals, Inc.
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with MAXCAPs
Login to view more data
100 Translational Medicine associated with MAXCAPs
Login to view more data
100 Patents (Medical) associated with MAXCAPs
Login to view more data
100 Deals associated with MAXCAPs
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nonalcoholic SteatohepatitisPreclinical
United States
Salix Pharmaceuticals, Inc.Salix Pharmaceuticals, Inc.
02 Apr 2019
Metabolic dysfunction-associated steatotic liver diseasePreclinical
United States
University of California, Los AngelesUniversity of California, Los Angeles
01 Apr 2019
Metabolic dysfunction-associated steatotic liver diseasePreclinical
Canada
Bausch Health Cos., Inc.Bausch Health Cos., Inc.
01 Apr 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free